Hong Yu is a Principal Scientist at Johnson & Johnson Innovative Medicine, specializing in molecular neuropharmacology related to AMPA receptors and their accessories. With a strong background in neuroscience drug discovery, they previously held roles at prominent companies including Eli Lilly and Pfizer, where they focused on targets such as nicotinic acetylcholine receptors and glycine transporters. Hong's early career includes significant contributions to the Human Genome Project and genetic studies on hereditary diseases at Genome Therapeutic Corporation. They hold a BS in Biology from East China Normal University and an MS in Biochemistry from Northeastern University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices